Clinical Trial Update: Efficacy of Fluoxetine - a Trial in Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of fluoxetine for stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Karolinska Institutet | Conditions: Stroke | Phase 3 | Status: COMPLETED